BTMD vs PATH · P/E 5.3, rev $197.2M vs P/E 19, rev $1.61B
biote Corp (BTMD) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
biote Corp (BTMD) is a medical care facilities company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported BTMD revenue for 2024-12-31 was $197.2M. Net income was $46.0K. Revenue was up 6.4% from 2023-12-31 to 2024-12-31. BTMD currently screens at market cap $80.7M and trailing P/E 5.3.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
BTMD currently screens at market cap $80.7M and trailing P/E 5.3. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the BTMD and PATH stock pages for the full models.
Not investment advice.